if you were to do an evauation of sales to current share price...

if you were to do an evauation of sales to current share price with money in bank .. they are selling to 400 stores at 2 bottles with a av profit per bottle of $3.00

so we are running at 15-20% potential in sales.
maybe 15% of market is not a grant for "product launch"..
only available online and a few pharmacys..

current share price is dazzling to say the least.. but i think the market is taking a extra cautious approach and valueing pno on current form not potential..
once we get a rollout, and some stats.. indepth ann.. we will then be re-rated imo.